Variability of Botulinum Toxins: Challenges and Opportunities for the Future by Christine Rasetti-Escargueil, Emmanuel Lemichez, Michel R. Popoff

Get full text

Antibodies and Vaccines against Botulinum Toxins: Available Measures and Novel Approaches by Christine Rasetti-Escargueil, Michel R. Popoff

Get full text

Recent Developments in Botulinum Neurotoxins Detection by Christine Rasetti-Escargueil, Michel R. Popoff

“…Therefore, fast, precise, and more reliable detection methods are still required to monitor outbreaks and ensure surveillance of botulism. The botulinum toxin field also comprises therapeutic uses, basic research studies and biodefense issues. …”
Get full text

Regulatory Networks Controlling Neurotoxin Synthesis in <i>Clostridium botulinum</i> and <i>Clostridium tetani</i> by Michel R. Popoff, Holger Brüggemann

“…<i>Clostridium botulinum</i> and <i>Clostridium tetani</i> are Gram-positive, spore-forming, and anaerobic bacteria that produce the most potent neurotoxins, botulinum toxin (BoNT) and tetanus toxin (TeNT), responsible for flaccid and spastic paralysis, respectively. …”
Get full text

Bacterial Toxins, Current Perspectives by Michel R. Popoff

“…Certain pathogenic bacteria synthesize only one toxin which is responsible for all the symptoms and outcome of the disease. For example, botulinum toxins (BoNTs) and tetanus toxin (TeNT) are the unique causal factors of botulism and tetanus, respectively. …”
Get full text

Engineering Botulinum Neurotoxins for Enhanced Therapeutic Applications and Vaccine Development by Christine Rasetti-Escargueil, Michel R. Popoff

“…This review summarizes current knowledge related to engineering of botulinum toxins, with particular emphasis on their potential therapeutic applications for pain management and for retargeting to non-neuronal tissues. …”
Get full text